CIK 0001730430 · Large accelerated filer
Kiniksa Pharmaceuticals International, plc
Sign in to watch- Ticker
- KNSA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 981795578
- Phone
- 7814319100
- Business address
- 105 PICCADILLY, SECOND FLOOR, LONDON, United Kingdom, W1J 7NJ
- Former names
- Kiniksa Pharmaceuticals, Ltd.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $78,588,440
- in 8 filings, $78.6M under 10b5-1 plans
Net −$78,588,440. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Patel Sanj K −$51.7M CHAIRMAN & CEO sold 42% of stake
- Moat Ross −$9.6M CHIEF OPERATING OFFICER sold 91% of stake
- Paolini John F. −$8.9M CHIEF MEDICAL OFFICER sold 58% of stake
- Megna Michael R −$4.9M CHIEF ACCOUNTING OFFICER sold 80% of stake
- Ragosa Mark −$3.4M CHIEF FINANCIAL OFFICER sold 64% of stake
Reading 59 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-04-01 | Moat Ross CHIEF OPERATING OFFICER | Grant or award · Performance Share Unit | +18,500 | 18,500 | ||
| 2026-04-01 | Moat Ross CHIEF OPERATING OFFICER | Option exercise · Restricted Share Unit | −1,611 | 1,161 | ||
| 2026-04-01 | Moat Ross CHIEF OPERATING OFFICER | Option exercise · Restricted Share Unit | −1,740 | 3,481 | ||
| 2026-04-01 | Moat Ross CHIEF OPERATING OFFICER | Option exercise · Restricted Share Unit | −2,457 | 7,371 | ||
| 2026-04-01 | Ragosa Mark CHIEF FINANCIAL OFFICER | Option exercise | +5,187 | 17,273 | ||
| 2026-04-01 | Ragosa Mark CHIEF FINANCIAL OFFICER | Shares withheld for taxes | −2,510 | $48.13 | $121K | 14,763 |
| 2026-04-01 | Ragosa Mark CHIEF FINANCIAL OFFICER | Grant or award · Share Option | +31,150 | 31,150 | ||
| 2026-04-01 | Ragosa Mark CHIEF FINANCIAL OFFICER | Grant or award · Restricted Share Unit | +7,800 | 7,800 | ||
| 2026-04-01 | Ragosa Mark CHIEF FINANCIAL OFFICER | Grant or award · Performance Share Unit | +15,600 | 15,600 | ||
| 2026-04-01 | Ragosa Mark CHIEF FINANCIAL OFFICER | Option exercise · Restricted Share Unit | −1,750 | 1,750 | ||
| 2026-04-01 | Ragosa Mark CHIEF FINANCIAL OFFICER | Option exercise · Restricted Share Unit | −1,591 | 3,182 | ||
| 2026-04-01 | Ragosa Mark CHIEF FINANCIAL OFFICER | Option exercise · Restricted Share Unit | −1,846 | 5,536 | ||
| 2026-04-01 | Paolini John F. CHIEF MEDICAL OFFICER | Option exercise | +5,831 | 67,155 | ||
| 2026-04-01 | Paolini John F. CHIEF MEDICAL OFFICER | Shares withheld for taxes | −2,821 | $48.13 | $136K | 64,334 |
| 2026-04-01 | Paolini John F. CHIEF MEDICAL OFFICER | Grant or award · Share Option | +26,750 | 26,750 | ||
| 2026-04-01 | Paolini John F. CHIEF MEDICAL OFFICER | Grant or award · Restricted Share Unit | +6,700 | 6,700 | ||
| 2026-04-01 | Paolini John F. CHIEF MEDICAL OFFICER | Grant or award · Performance Share Unit | +13,400 | 13,400 | ||
| 2026-04-01 | Paolini John F. CHIEF MEDICAL OFFICER | Option exercise · Restricted Share Unit | −1,624 | 1,624 | ||
| 2026-04-01 | Paolini John F. CHIEF MEDICAL OFFICER | Option exercise · Restricted Share Unit | −1,750 | 3,500 | ||
| 2026-04-01 | Paolini John F. CHIEF MEDICAL OFFICER | Option exercise · Restricted Share Unit | −2,457 | 7,371 |
Page 15 of 74 · 1,467 trades